We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.78B
AUM Growth
-$1.14B
Cap. Flow
-$1.45B
Cap. Flow %
-81.2%
Top 10 Hldgs %
51.86%
Holding
95
New
12
Increased
22
Reduced
11
Closed
15

Top Buys

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$28.4M
2
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
+$20.2M
3
NRE
NorthStar Realty Europe Corp.
NRE
+$18.1M
4
Z icon
Zillow
Z
+$11.2M
5
MRVL icon
Marvell Technology
MRVL
+$10.6M

Top Sells

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$969M
2
ABUS icon
Arbutus Biopharma
ABUS
+$97.5M
3
EBAY icon
eBay
EBAY
+$31M
4
CALM icon
Cal-Maine
CALM
+$25.7M
5
VNET
VNET Group
VNET
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 12.55%
2 Real Estate 4.77%
3 Communication Services 3.87%
4 Technology 3.82%
5 Financials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
26
Goldman Sachs
GS
$313B
$13.5M 0.76%
75,000
– –
TNK icon
27
Teekay Tankers
TNK
$2.63B
$12.5M 0.7%
227,674
+144,267
+173% +$8.48M
AGEN
28
Agenus
AGEN
$249M
$12.2M 0.68%
136,562
– –
ARWR icon
29
Arrowhead Research
ARWR
$12.1B
$12M 0.67%
1,951,382
– –
VNET
30
VNET Group
VNET
$2.05B
$11.1M 0.62%
525,189
-1,009,971
-66% -$20.2M
IOVA icon
31
Iovance Biotherapeutics
IOVA
$2.23B
$11.1M 0.62%
1,433,700
– –
FPRX
32
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$10.2M 0.58%
246,848
-121,514
-33% -$4.07M
Z icon
33
Zillow
Z
$7.04B
$9.98M 0.56%
+425,000
New +$11.2M
NXEO
34
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$9.96M 0.56%
1,000,000
– –
EPZM
35
DELISTED
Epizyme, Inc
EPZM
$9.54M 0.54%
595,314
-58,514
-9% -$867K
W icon
36
Wayfair
W
$11.1B
$9.52M 0.53%
200,000
+25,000
+14% +$1.06M
W icon
37
PUT
Wayfair
W
$11.1B
$9.52M 0.53%
200,000
-200,000
-50% -$8.46M
ZG icon
38
Zillow
ZG
$7.02B
$9.11M 0.51%
350,000
+250,000
+250% +$7.13M
BONA
39
DELISTED
BONA FILM GROUP LTD SPONSORED ADS
BONA
$8.46M 0.47%
639,211
– –
HALO icon
40
Halozyme
HALO
$9.72B
$8.43M 0.47%
486,276
– –
BRFS
41
DELISTED
BRF SA
BRFS
$8.39M 0.47%
607,112
– –
JPM icon
42
JPMorgan Chase
JPM
$939B
$8.38M 0.47%
126,879
+36,879
+41% +$2.4M
FCSC
43
DELISTED
Fibrocell Science Inc.
FCSC
$8.34M 0.47%
127,577
+2,873
+2% +$206K
ADAP
44
DELISTED
Adaptimmune Therapeutics
ADAP
$8.03M 0.45%
665,566
+315,566
+90% +$3.09M
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.94M 0.45%
251,137
-26,596
-10% -$939K
BLCM
46
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$6.91M 0.39%
34,099
+2,325
+7% +$416K
FSLR icon
47
PUT
First Solar
FSLR
$21.8B
$6.6M 0.37%
100,000
– –
XNCR icon
48
Xencor
XNCR
$1.44B
$5.66M 0.32%
386,925
– –
GNMX
49
DELISTED
Aevi Genomic Medicine Inc
GNMX
$5.22M 0.29%
867,608
+600,000
+224% +$4.07M
RGNX icon
50
Regenxbio
RGNX
$623M
$5.18M 0.29%
+351,525
New +$6.98M
1
2
3 4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q4 2015 Portfolio in Review

As of Q4 2015, QVT Financial held 95 positions worth $1.78B, down 39% from $2.92B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

QVT Financial withdrew a net $1.45B in Q4 2015, closing 15 positions and reducing 11 holdings. Its most notable exit was Sio Gene Therapies Inc. Common Stock, an estimated $969M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 43% a quarter earlier, followed by Real Estate and Communication Services.

Against the trend, QVT Financial opened a new position in SANDISK CORP worth $29.5M.

  • QVT Financial's largest Q4 2015 buy was SANDISK CORP: 387,805 shares worth $29.5M.
  • QVT Financial added most to Marvell Technology in Q4 2015, an estimated $10.6M increase.
  • QVT Financial's biggest Q4 2015 reduction was VNET Group, cutting an estimated $20.2M.
  • QVT Financial fully exited Sio Gene Therapies Inc. Common Stock in Q4 2015, selling an estimated $969M.
  • QVT Financial's ten largest holdings make up 52% of its $1.78B portfolio in Q4 2015.
  • QVT Financial opened 12 new positions and closed 15 in Q4 2015.
  • QVT Financial's portfolio value fell 39% quarter-over-quarter to $1.78B.

Based on QVT Financial's 13F filing for Q4 2015, filed 16 Feb 2016.